Selker Harry P, Daudelin Denise H, Ruthazer Robin, Kwong Manlik, Lorenzana Rebecca C, Hannon Daniel J, Wong John B, Kent David M, Terrin Norma, Moreno-Koehler Alejandro D, McAlindon Timothy E
Tufts Clinical and Translational Science Institute, Tufts University, Boston, Massachusetts, USA.
Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, USA.
J Clin Transl Sci. 2019 Feb;3(1):27-36. doi: 10.1017/cts.2019.380.
To enhance enrollment into randomized clinical trials (RCTs), we proposed electronic health record-based clinical decision support for patient-clinician shared decision-making about care and RCT enrollment, based on "mathematical equipoise."
As an example, we created the Knee Osteoarthritis Mathematical Equipoise Tool (KOMET) to determine the presence of patient-specific equipoise between treatments for the choice between total knee replacement (TKR) and nonsurgical treatment of advanced knee osteoarthritis.
With input from patients and clinicians about important pain and physical function treatment outcomes, we created a database from non-RCT sources of knee osteoarthritis outcomes. We then developed multivariable linear regression models that predict 1-year individual-patient knee pain and physical function outcomes for TKR and for nonsurgical treatment. These predictions allowed detecting mathematical equipoise between these two options for patients eligible for TKR. Decision support software was developed to graphically illustrate, for a given patient, the degree of overlap of pain and functional outcomes between the treatments and was pilot tested for usability, responsiveness, and as support for shared decision-making.
The KOMET predictive regression model for knee pain had four patient-specific variables, and an value of 0.32, and the model for physical functioning included six patient-specific variables, and an of 0.34. These models were incorporated into prototype KOMET decision support software and pilot tested in clinics, and were generally well received.
Use of predictive models and mathematical equipoise may help discern patient-specific equipoise to support shared decision-making for selecting between alternative treatments and considering enrollment into an RCT.
为了提高随机临床试验(RCT)的入组率,我们基于“数学平衡”,提出了基于电子健康记录的临床决策支持,用于患者与临床医生关于治疗和RCT入组的共同决策。
作为一个例子,我们创建了膝关节骨关节炎数学平衡工具(KOMET),以确定在全膝关节置换(TKR)和晚期膝关节骨关节炎非手术治疗之间选择时,针对特定患者的治疗方案之间是否存在平衡。
我们从患者和临床医生那里获取了关于重要疼痛和身体功能治疗结果的信息,创建了一个来自膝关节骨关节炎非RCT研究结果的数据库。然后,我们开发了多变量线性回归模型,用于预测TKR和非手术治疗的1年个体患者膝关节疼痛和身体功能结果。这些预测有助于检测符合TKR条件的患者在这两种选择之间的数学平衡。我们开发了决策支持软件,以图形方式为给定患者说明两种治疗之间疼痛和功能结果的重叠程度,并对其可用性、响应性以及对共同决策的支持进行了试点测试。
膝关节疼痛的KOMET预测回归模型有四个特定于患者的变量,R²值为0.32,身体功能模型包括六个特定于患者的变量,R²为0.34。这些模型被纳入KOMET决策支持软件原型,并在诊所进行了试点测试,总体上受到好评。
使用预测模型和数学平衡可能有助于辨别特定于患者的平衡,以支持在替代治疗之间进行选择并考虑纳入RCT的共同决策。